These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17872954)

  • 1. Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector.
    Dixon N; Páli T; Kee TP; Ball S; Harrison MA; Findlay JB; Nyman J; Väänänen K; Finbow ME; Marsh D
    Biophys J; 2008 Jan; 94(2):506-14. PubMed ID: 17872954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
    Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
    Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain.
    Whyteside G; Meek PJ; Ball SK; Dixon N; Finbow ME; Kee TP; Findlay JB; Harrison MA
    Biochemistry; 2005 Nov; 44(45):15024-31. PubMed ID: 16274249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of transmembrane peptides from the vacuolar H(+)-ATPase in phospholipid membranes: spin-label electron paramagnetic resonance and polarized infrared spectroscopy.
    Kóta Z; Páli T; Dixon N; Kee TP; Harrison MA; Findlay JB; Finbow ME; Marsh D
    Biochemistry; 2008 Mar; 47(12):3937-49. PubMed ID: 18307317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spin-labelled vacuolar-ATPase inhibitors in lipid membranes.
    Dixon N; Páli T; Kee TP; Marsh D
    Biochim Biophys Acta; 2004 Oct; 1665(1-2):177-83. PubMed ID: 15471583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies.
    Páli T; Dixon N; Kee TP; Marsh D
    Biochim Biophys Acta; 2004 May; 1663(1-2):14-8. PubMed ID: 15157605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of a hybrid vacuolar H(+)-ATPase in Saccharomyces cells expressing the Nephrops 16-kDa proteolipid.
    Harrison MA; Jones PC; Kim YI; Finbow ME; Findlay JB
    Eur J Biochem; 1994 Apr; 221(1):111-20. PubMed ID: 8168500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPR Studies of V-ATPase with Spin-Labeled Inhibitors DCC and Archazolid: Interaction Dynamics with Proton Translocating Subunit c.
    Gölz JP; Bockelmann S; Mayer K; Steinhoff HJ; Wieczorek H; Huss M; Klare JP; Menche D
    ChemMedChem; 2016 Feb; 11(4):420-8. PubMed ID: 26662886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first putative transmembrane segment of subunit c" (Vma16p) of the yeast V-ATPase is not necessary for function.
    Nishi T; Kawasaki-Nishi S; Forgac M
    J Biol Chem; 2003 Feb; 278(8):5821-7. PubMed ID: 12482875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of dibutyltin-3-hydroxyflavone bromide with the 16 kDa proteolipid indicates the disposition of proton translocation sites of the vacuolar ATPase.
    Hughes G; Harrison MA; Kim YI; Griffiths DE; Finbow ME; Findlay JB
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):425-31. PubMed ID: 8713068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding assays of inhibitors towards selected V-ATPase domains.
    Fernandes F; Loura LM; Fedorov A; Dixon N; Kee TP; Prieto M; Hemminga MA
    Biochim Biophys Acta; 2006 Nov; 1758(11):1777-86. PubMed ID: 16996024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first putative transmembrane helix of the 16 kDa proteolipid lines a pore in the Vo sector of the vacuolar H(+)-ATPase.
    Jones PC; Harrison MA; Kim YI; Finbow ME; Findlay JB
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):739-47. PubMed ID: 8554514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.
    Gagliardi S; Nadler G; Consolandi E; Parini C; Morvan M; Legave MN; Belfiore P; Zocchetti A; Clarke GD; James I; Nambi P; Gowen M; Farina C
    J Med Chem; 1998 May; 41(10):1568-73. PubMed ID: 9572882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the rotation rate in the vacuolar proton-ATPase in native yeast vacuolar membranes.
    Ferencz C; Petrovszki P; Kóta Z; Fodor-Ayaydin E; Haracska L; Bóta A; Varga Z; Dér A; Marsh D; Páli T
    Eur Biophys J; 2013 Mar; 42(2-3):147-58. PubMed ID: 23160754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A divalent-ion binding site on the 16-kDa proton channel from Nephrops norvegicus--revealed by EPR spectroscopy.
    Páli T; Finbow ME; Marsh D
    Biochim Biophys Acta; 2006 Feb; 1758(2):206-12. PubMed ID: 16545340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane assembly of the 16-kDa proteolipid channel from Nephrops norvegicus studied by relaxation enhancements in spin-label ESR.
    Páli T; Finbow ME; Marsh D
    Biochemistry; 1999 Oct; 38(43):14311-9. PubMed ID: 10572006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis and characterization of vacuolar-type H+ -ATPase proteolipid transcript from Acanthus ebracteatus Vah1.
    Ho CL; Nguyen PD; Harikrishna JA; Rahim RA
    DNA Seq; 2008 Feb; 19(1):73-7. PubMed ID: 17852357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the yeast vacuolar H+-ATPase proton pore.
    Powell B; Graham LA; Stevens TH
    J Biol Chem; 2000 Aug; 275(31):23654-60. PubMed ID: 10825180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.